New Strategies for GlaxoSmithKline

소개글

글락소스미스클라인의 역사, 기업분석(SWOT), 현재 시장 점유율, 추후 가능한 전략들에 대해서
상세히 서술하였습니다. 영문판이며 상당히 잘된 리포트입니다. 제약쪽에 리포트 쓰실 분들은
이 리포트 참고하면 좋을듯해요.

목차

□ Introduction of GlaxoSmithKline
□ Pharmaceutical industry
□ Five forces analysis of the pharmaceutical industry
□ SWOT analysis of GSK
□ Hot Issue, Patent Protection and GSK
□ Three Signs of New wave

본문내용

□ Introduction of GlaxoSmithKline
GlaxoSmithKline is one of the major pharmaceutical company in the world. In December 27th, of 2000 Glaxo Wellcome and SmithKline Beecham agreed to merge two companies creating what is now known as GlaxoSmithKline. Glaxo Wellcome and SmithKline Beecham were major players in global healthcare business. GSK is engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products. GSK has its corporate head office in London. It also has operational headquarters in Philadelphia and Research Triangle Park, USA. GSK operates in 117 countries, with products sold in 140 countries. The principal research and development facilities are in the UK, the USA, Japan, Italy, Spain and Belgium. Products are currently manufactured in 37 countries.

□ Five forces analysis of the pharmaceutical industry
1) Entry Barrier – high
Entry barrier is high because it requires huge capital investment. Since it needs huge investment and time to develop and manufacture new medicine, new companies have difficulties in entering

참고 자료

없음